capecitabine
roche
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
neoadjuvant therapy with mfolfox6/capox in local crc 3-year dfs 78% vs 76%, ns
3-year os 95% vs 88%, p=0.01 foxtrott revisited -&gt; feasible, but not practice changing. 
Physician-scientist, focussed on translational research in hepatobiliary cancer and precision medicine